Exploratory research on Anti-SARS-CoV-2 testing

Exploratory research on Anti-SARS-CoV-2 testing by the Blood Collection Device OneDraw

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs052200157

Enrollment

Registered

2021-03-17

Start date

2021-03-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 patients

Interventions

Blood collection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COVID-19 patients confirmed by nucleic amplification testing Those who were vaccinated with COVID-19 vaccine at least 2 weeks ago

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Correlation of SARS-CoV-2 titer between whole blood obtained by novel blood collecting device and matched serum.	—

Contacts

Public ContactMiki Nagao

Kyoto University Graduate School of Medicine

mnagao@kuhp.kyoto-u.ac.jp+81-757513502

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026